What is the focus of Global BioPharma Consulting?
Aleks: Our clients are the biotechnology companies that use recombinant genetic engineering to develop products and the biopharmas that are using biology and chemistry together to develop products for human therapeutics, diagnostics, drug delivery, and cell and gene therapy. Our customers encompass many diverse market segments, including drug developers, Contract Research Organizations, HTS/combichem companies, and proteomics/genomics specialists.
We support customers worldwide, excepting only MDL’s largest corporate customers (which are the responsibility of John’s group) and customers in Japan and South Korea (where MDL Information Systems Japan KK offers full sales and service support). Our customers range from large, global enterprises through small to mid-sized companies, all the way to the smallest start-ups. The needs of our larger clients are similar to those of John’s group, obviously with somewhat less complexity, because the companies we serve may not have such extensive global operations. Our smaller customers, on the other hand, tend to have distinct requirements. They typically want out-of-the-box solutions, very well integrated across all their research informatics needs, and the ability to deploy new technology quickly and to measure immediate productivity improvements.
